In this study, our results demonstrate that brevilin A suppresses PI3K/AKT/mTOR activity in CNE-2 cells and in in vivo CNE-2 tumor xenografts, which may be associated with inhibition of NPC cell proliferation and induction of apoptosis. This evidence concerns the gene AKT1 and neoplasm.